Projects per year
Personal profile
Education/Academic qualification
Infectious Diseases, Clinical Fellowship, University of Texas Health Science Center at Houston
Jul 1 2005 → Jun 1 2007
Award Date: Jun 1 2007
Internal Medicine, Residency, University of Texas Health Science Center at Houston
Jul 1 2003 → Jun 1 2005
Award Date: Jun 1 2005
Internal Medicine, Internship, University of Texas Health Science Center at Houston
Jul 1 2007 → Jun 1 2003
Award Date: Jun 1 2003
MD, University of Texas Health Science Center at Houston
Aug 1 1997 → May 1 2002
Award Date: May 1 2002
Research Area Keywords
- Clinical Care
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A Phase III, adjudicator-blinded, randomised study to evaluate the efficacy and safety of treatment with olorofim versus treatment with AmBisome® followed by standard of care (SOC) in patients with invasive fungal disease (IFD) caused by Aspergillus species
Grimes, K. A., Lin, J., Malik, A. I. & Nigo, M.
11/16/23 → …
Project: Clinical Trial
-
BAT IT: Banked Anti- SARS Cov-2 T cell Infusions for Treatment of COVID-19
10/1/20 → 3/31/22
Project: Non Profit
Research output
- 13 Article
-
Bloodstream infections after solid organ transplantation: clinical epidemiology and antimicrobial resistance (2016–21)
Adelman, M. W., Connor, A. A., Hsu, E., Saharia, A., Mobley, C. M., Victor, D. W., Hobeika, M. J., Lin, J., Grimes, K. A., Ramos, E., Pedroza, C., Brombosz, E. W., Ghobrial, R. M. & Arias, C. A., Feb 1 2024, In: JAC-Antimicrobial Resistance. 6, 1, 158.Research output: Contribution to journal › Article › peer-review
Open Access -
Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients
Vasileiou, S., Hill, L. Q., Kuvalekar, M., Workineh, A. G., Watanabe, A., Velazquez, Y., Lulla, S., Mooney, K., Lapteva, N., Grilley, B. J., Heslop, H. E., Rooney, C. M., Brenner, M. K., Eagar, T. N., Carrum, G., Grimes, K. A., Leen, A. M. & Lulla, P., Jul 1 2023, In: Haematologica. 108, 7, p. 1840-1850 11 p.Research output: Contribution to journal › Article › peer-review
Open Access12 Scopus citations -
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections
Sweeney, D. A., Tuyishimire, B., Ahuja, N., Beigel, J. H., Beresnev, T., Cantos, V. D., Castro, J. G., Cohen, S. H., Cross, K., Dodd, L. E., Erdmann, N., Fung, M., Ghazaryan, V., George, S. L., Grimes, K. A., Hynes, N. A., Julian, K. G., Kandiah, S., Kim, H. J., Levine, C. B., & 10 others , May 1 2023, In: Open Forum Infectious Diseases. 10, 5, p. ofad205 ofad205.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Bloodstream infections in prolonged use of axillary-placed, intra-aortic balloon-pump support: A single-center study
Dreucean, D., Donahue, K. R., Morton, C., Succar, L., Krisl, J., Agrawal, T., Perez, K., Jaramillo, T., Kim, J., Fida, N., Guha, A., Kassi, M., Yousefzai, R., Hussain, I., Grimes, K. & Bhimaraj, A., Nov 10 2023, (E-pub ahead of print) In: Infection Control and Hospital Epidemiology. p. 1-3 3 p.Research output: Contribution to journal › Article › peer-review
-
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
ACTT-4 Study Group, Sep 2022, In: The Lancet Respiratory Medicine. 10, 9, p. 888-899 12 p.Research output: Contribution to journal › Article › peer-review
61 Scopus citations